Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Obesity (Silver Spring). 2009 Nov 12;18(6):1176–1182. doi: 10.1038/oby.2009.409

Table 2. Results of pre-lunch appetite questionnaires on days 1-4 for subjects who completed both visits (using LOCF*).

Walnut Placebo P1 P2 P3
Full 0.05
 Day1 32.3 ± 6.5 23.6 ± 6.8 0.26 0.3
 Day2 37.5 ± 8.3 24.6 ± 4.4 0.2 0.33
 Day3 27.6 ± 6.8 14.6 ± 3.8 0.03 0.03
 Day4 30.7 ± 5.1 22.3 ± 5.4 0.14 0.13
Satiety 0.01
 Day1 38.5 ± 6.7 33 ± 7.3 0.56 0.9
 Day2 45.7 ± 8.2 33.1 ± 5.3 0.25 0.37
 Day3 43.1 ± 7.5 19.4 ± 4.4 0.01 0.02
 Day4 38.8 ± 6.8 19.6 ± 4.7 0.02 0.03
Hungry 0.17
 Day1 68.2 ± 6.9 63.5 ± 6.8 0.5 0.64
 Day2 55.7 ± 8.2 59.4 ± 7.2 0.68 0.86
 Day3 62.3 ± 7.7 68.9 ± 7.7 0.45 0.27
 Day4 59.8 ± 7.2 52.7 ± 8.3 0.16 0.31

Values are millimeters on a visual analog scale; means ± SE are presented

1

p-value is based on Wilcoxon signed rank test

2

p-value is based on paired T-test and mixed model controlled for sequence which have same results

3

p-value is based on repeated measures analysis to compare differences between walnut and placebo groups over four days of period.

*

LOCF: Last observation carried forward